LAGAGREL 75 mg price in UAE

Overview

Welcome to Dwaey, specifically on LAGAGREL 75 mg Tablet/ Film coated page.
This medicine contains an important and useful components, as it consists of Clopidogrel.
LAGAGREL 75 mg is available in the market in concentration 75 mg/ tablet and in the form of Tablet/ Film coated.

LAGAP SA is the producer of LAGAGREL 75 mg and it is imported from UAE, The most popular alternatives of LAGAGREL 75 mg are listed downward .

Mode Of Action

Clopidogrel inhibits adenosine diphosphate (ADP) from binding to its receptor sites on the platelets and subsequent activation of glycoprotein GP IIb/IIIa complex thus preventing fibrinogen binding, platelet adhesion and aggregation.

Indication

Coronary Artery Disease
Acute coronary syndrome
Myocardial infarction
Peripheral vascular disease
Cerebrovascular disease
Atherosclerosis
Thromboembolic disorders
Unstable angina
Stroke

Precaution

Patients at risk of increased bleeding from trauma, surgery, or other pathological conditions; ulcer; renal and hepatic impairment; history of bleeding or haemostatic disorders. Pregnancy. Lactation: Not known whether drug is excreted in breast milk; not recommended

Side Effects

1-10% Upper respiratory tract infection (8.7%)
Chest pain (8.3%)
Headache (7.6%)
Flulike syndrome (7.5%)
Arthralgia (6%)
Pain (6%)
Dizziness (6%)
Diarrhea (4.5%)
Rash (4.2%)
Rhinitis (4.2%)
Depression (3.6%)
Urinary tract infection (3.1%) <1% Severe neutropenia
Thrombotic thrombocytopenic purpura
Acute liver failure
Aplastic anemia
Hypotension
Hepatitis
Myalgia
Eczema
Erythema
Agranulocytosis Potentially Fatal: Bleeding disorders including GI and intracranial haemorrhage. Blood dyscrasias.

Contra indication

Hypersensitivity. Active pathological bleeding. admin within 7 days after MI and ischaemic stroke, coagulation disorders. Lactation.

Pregnancy and lactation

Pregnancy category: B

Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Interaction

Co-admin with NSAIDs may increase the risk of stomach and intestinal bleeding. High-dose clopidogrel may lead to increased warfarin levels thus increasing the risk of bleeding. High-dose clopidogrel may also inhibit P450 (2C9), thus interfering with the metabolism of phenytoin, tamoxifen, torasemide, fluvastatin and some NSAIDs. Avoid c